Stay updated on Incyte Press Releases

Sign up to get notified when there's something new on the Incyte Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Incyte Press Releases page

  1. Check
    4 days ago
    Change Detected
    Summary
    Incyte has announced its participation in an upcoming investor conference on December 17, 2024, while the report on its third quarter financial results from October 29, 2024, has been removed.
    Difference
    13%
    Check dated 2024-12-22T07:29:28.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Incyte has added late-breaking data on Tafasitamab (Monjuvi®) showing improved progression-free survival for follicular lymphoma at ASH 2024, while it has been removed from the list of top employers by Science Magazine.
    Difference
    20%
    Check dated 2024-12-14T23:17:38.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Incyte has announced positive results from a Phase 3 trial of Retifanlimab in combination with chemotherapy for non-small cell lung cancer, while recent updates include inducement grants under Nasdaq rules, following the removal of previous announcements related to atopic dermatitis and third quarter financial results.
    Difference
    37%
    Check dated 2024-12-07T19:14:07.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Incyte has updated the presentation time for an upcoming investor conference and will highlight new data, including a late-breaking oral presentation for Tafasitamab in Follicular Lymphoma, at the 2024 ASH Annual Meeting.
    Difference
    32%
    Check dated 2024-11-30T16:43:42.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Incyte has provided an update on its early phase MRGPRX2 and MRGPRX4 programs as of November 18, 2024, while a previous announcement regarding late-breaking data presentations at the EADV 2024 Congress has been removed.
    Difference
    21%
    Check dated 2024-11-23T05:51:59.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Incyte has announced its upcoming presentation at an investor conference on November 14, 2024, while a previous announcement regarding a publication related to the AGAVE-201 trial has been removed.
    Difference
    17%
    Check dated 2024-11-16T01:28:46.000Z thumbnail image

Stay in the know with updates to Incyte Press Releases

Enter your email address, and we'll notify you when there's something new on the Incyte Press Releases page.